在功能性外部记忆辅助工具中最大限度地发挥"功能性",用于以患者为中心的治疗规划,以轻度认知障碍为中心
Alyssa M Lanzi1,2, Julia L Mendez3, Megan Tobin3
1Department of Communication Sciences & Disorders, University of Delaware, Newark.
American journal of speech-language pathology
|October 17, 2024
概括
功能外部记忆辅助工具 (FEMAT) 有助于评估轻度认知障碍患者在日常任务中如何使用记忆辅助工具和策略. 分析显示,参与者经常讨论策略和他们的记忆,为个性化治疗提供了见解.
科学领域:
- 老年学是指老年学的学科.
- 神经心理学 神经心理学
- 康复科学 康复科学 康复科学
背景情况:
- 功能外部记忆辅助工具 (FEMAT) 是一项11项措施,用于评估模拟日常任务中的补偿策略.
- 它旨在以标准化格式向临床医生提供有关患者功能和补偿的信息,而不是作为诊断工具.
研究的目的:
- 为FEMAT的有效性提供进一步的证据.
- 进行FEMAT反应的混合方法分析,以操作化测试管理期间引起的行为.
主要方法:
- 使用了一个嵌入式单个案例研究设计.
- 分析了12名生活在社区的女性参与者 (73-90岁) 轻度认知障碍.
- 视频录制和转录的FEMAT药物被分析为质量 (主题分析) 和数量.
主要成果:
- 出现在四个主题:使用外部记忆辅助器 (EMA),描述策略,讨论记忆/理解,以及讨论功能信息.
- 大多数参与者描述了使用策略 (85%) 并讨论了自我感知记忆/理解 (33%).
- 副主题包括自我感知的记忆强度和障碍.
结论:
- FEMAT引发了超越项目分数的有价值的行为和口头内容,对以人为中心的治疗规划有用.
- 这项研究支持FEMAT的有效性,为个人化治疗方法提供信息.
- 进一步的研究旨在为FEMAT的有效性建立全面的证据.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
106
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
106
Cognitive Development During Adulthood
65
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
65
Alzheimer's Disease: Treatment
166
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
166
Working Memory
138
Working memory refers to a combination of components, including short-term memory and attention, that allow an individual to hold information temporarily as we perform cognitive tasks. It is an essential cognitive function that enables the execution of complex tasks such as problem-solving, comprehension, and reasoning. Unlike short-term memory, which simply involves the storage of information for a brief period, working memory involves the active manipulation and processing of this...
138
Mnemonic Devices
61
Mnemonic devices are cognitive tools that facilitate memory retention by linking new information to familiar patterns or organizational strategies. These techniques are beneficial for remembering complex or lengthy sets of information by simplifying and structuring them in easily retrievable ways.
Acronyms
Acronyms are created by using the initial letters of a series of words to form a new word or phrase. This approach condenses complex information into a single, memorable entity. For example,...
Acronyms
Acronyms are created by using the initial letters of a series of words to form a new word or phrase. This approach condenses complex information into a single, memorable entity. For example,...
61


